Languages: English Español
Currencies:
TO ALL CUSTOMERS PLEASE TAKE NOTICE: Many customers felt secure by using credit cards because they had recourse if their meds were not delivered. This is something we understand since we all have credit or debit cards. Unbeknown to most, Stephen Cohen is not only our legal representative but he is also the Sr. Vice President of Security Pacific National Bank in Mexico®. The bank is the 100% owner of BajaPay.com.

On October 22, 2014, Medicina Mexico signed a contract with Security Pacific Bank to collect all of our customer's payments through Mr. Cohen. Your funds are now going to be escrowed until you receive delivery. What this means is no funds will be turned over to Medicina Mexico until you receive your medications. If you do not receive your medications within the time allowed, you will receive a full refund.

Every business with common sense knows that keeping your customers happy, secure and safe is more important than making money and will always result in repeat customers.

Licensed pharmacies in Mexico are only allowed to sell medications, either brands or generics, from an approved pharmaceutical which has passed testing and has subsequently been authorized by the Mexican Government.

If you look on the left at About US you will see our licenses, permits and our Regulatory Body. Our goal is to offer you the best possible prices with excellent service. When you place an order to ensure our messages reach your mailbox (and not the spam folder), please add sales@meds.com.mx to your addresses book.

All of our pharmacies are open 24 hours a day, 365 days per year. We speak Spanish and English.

   
   
Categories
 
Pharmaceuticials
 
Information
 

ORLISTAT 120MG C/21 CAPS

ORLISTAT 120MG C/21 CAPS
SKU #:FA, DF EQ
Current Reviews:0
Price:$22.10
 

ORLISTAT 120MG C/21 CAPS

Orlistat is used for the treatment of obesity. The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% and 24.8% achieved at least a 10% decrease in body mass. After orlistat was stopped, a significant number of subjects regained weight—up to 35% of the weight they had lost.

The incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%).Long-term use of orlistat also leads to a modest reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood pressure respectively).

Orlistat is notorious for its gastrointestinal side effects which are oily and loose stools. These decrease with time, however, and are the most frequently reported adverse effects of the drug.

Its primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake.

For more information, please contact your medical doctor.


   
   
   
Shopping Cart:
now in your cart 0 items
   
Manufacturer Info
 
 
Affiliates